Bayer Healthcare LLC

Henry Hernaez

Arthur E Uber, Iii

Kevin P Cowan

David M Griffiths

Roey Flor

Sridhar R Balasubramanian

Robert Redmond

Ivana Kingston

Dzmitry Liushtyk

Matthew Hoiko

Franco Fois

Karym El Sayed

Daniel Rechsteiner

Wei Liao

Jacob Agris

Mohammad Sedigh Ghamari

Xiangzhen Gao

Prahlad Menon Gopalakrishna

Nivitha Mahesh

Gopalakrishna Prahlad Menon

Described are systems and methods for assessing a likelihood of chronic thromboembolic pulmonary hypertension (CTEPH) within a subject patient based upon an analysis of characteristics indicative of chronic thromboembolic pulmonary hypertension within an imaging study of the subject patient. The systems and methods can identify characteristics of one or more anatomical structures within a cardiac region of the subject patient indicative of CTEPH, characteristics of a pulmonary vasculature of the subject patient indicative of CTEPH, and characteristics of a chronic abnormality in a lung of the subject patient indicative of CTEPH. The systems and methods can assess these characteristics to compute the likelihood of CTEPH within the subject patient.

Systems and methods for assessing a likelihood of CTEPH and identifying characteristics indicative thereof

Described is an in-scan phantom for use during an imaging procedure. The phantom can include at least one measuring insert and/or at least one measured insert. The measuring insert may have radiation detecting capabilities while the measured insert may include a radioactive material. Also described is an imaging modality system that includes an imaging modality and an in-scan phantom as well as methods of using the in-scan phantom for imaging a patient or performing a scout scan.

Quantification phantom for use with multiple imaging modalities

Growing community of inventors

Pittsburgh, PA, United States of America

Henry Hernaez